MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0031477
Novatro Laboratories Private Limited
Novatro Laboratories Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹9.35 Cr
Latest filing
Net profit · FY 2023
₹5.31 Lakh
Net margin 0.6%
EBITDA · FY 2023
₹7.71 Lakh
EBITDA margin 0.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
About Novatro Laboratories Private Limited
Data last updated:
Novatro Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC399347. Its GSTIN is 05AAICN2823K1ZF (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sharat Chandra Jha and Tilak Ram.
Its last annual general meeting (AGM) was held on 31 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Office No – 606 6th Floor Laxmi Deep Building District Centre, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹9.35 Cr. For the same year it recorded a net profit of ₹5.31 Lakh (net margin 0.6%) and EBITDA of ₹7.71 Lakh (EBITDA margin 0.8%).
As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 13 cases involving the company, including 13 filed against it; 13 cases are pending.
Novatro Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0031477). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230DL2022PTC399347
Registration Number 399347
Incorporation Date 31 May 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0031477
Key People
Sharat Chandra Jha Director Tilak Ram Director Recognitions & Rankings of Novatro Laboratories
Contact details
Novatro Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No – 606 6th Floor Laxmi Deep Building District Centre, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novatro Laboratories Private Limited, buy the company report.
Comprehensive company report
Novatro Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Novatro Laboratories Private Limited
FY 2023 filings availableNovatro Laboratories Private Limited reported revenue of ₹9.35 Cr for FY 2023.
Revenue · FY 2023
₹9.35 Cr
Net profit · FY 2023
₹5.31 Lakh margin 0.6%
EBITDA · FY 2023
₹7.71 Lakh margin 0.8%
Financial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹9.35 Cr |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹7.71 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹5.31 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | 0.8% |
| Net Profit Margin | 0.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Novatro Laboratories Private Limited, buy the company report.
Board of directors of Novatro Laboratories Private Limited
Novatro Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharat Chandra Jha | Director | 31 May 2022 | 4 Years 5 Months | Current |
| Tilak Ram Also directs: Wirmon Laboratories Private Limited | Director | 31 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Novatro Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zevemed Healthcare Private Limited | ₹9.39 Cr (FY 2024) | 117.0% | Secunderabad, Telangana, India | |||
| Organon Homoeo Laboratory Pvt Ltd | ₹9.39 Cr (FY 2025) | 10.0% | Kolkata, West Bengal, India | |||
| Emmchak Formulations Private Limited | ₹9.37 Cr (FY 2025) | 11.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Unicorn Pharmachem Private Limited | ₹9.36 Cr (FY 2024) | -48.0% | Mumbai, Maharashtra, India | |||
| Asterisk Laboratories India Private Limited | ₹9.35 Cr (FY 2025) | -5.0% | Chandigarh, India | |||
| Novatro Laboratories Private Limitedthis company | ₹9.35 Cr (FY 2023) | ₹5.31 Lakh | 0.6% | New Delhi, Delhi, India | ||
| Osbro Pharmaceutical Private Limited | ₹9.34 Cr (FY 2022) | -11.0% | Pune, Maharashtra, India | |||
| Uniqlife Biosciences Private Limited | ₹9.34 Cr (FY 2025) | 18.0% | Agra, Uttar Pradesh, India | |||
| Idealife Healthcare Limited | ₹9.32 Cr (FY 2025) | 11.0% | Kanpur, Uttar Pradesh, India | |||
| Palmo Industrial Silicones Private Limited | ₹9.32 Cr (FY 2025) | 7.0% | Vadodara, Gujarat, India | |||
| Bohra Lifescience Private Limited | ₹9.28 Cr (FY 2024) | 115.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Novatro Laboratories Private Limited, buy the company report.
Auditor
Novatro Laboratories Private Limited is audited by M/s RANJIT YADAV AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s RANJIT YADAV AND ASSOCIATES | FY 2023 | 039605N |
Shareholding
The shareholding of Novatro Laboratories Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Novatro Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2023 | 100861996 | State Bank of India | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Novatro Laboratories Private Limited has 13 court cases on record: 13 filed against it. All cases are pending.
Total cases
13
Filed against the company
13
Pending
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 13 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Household Remedies Pvt Ltd Through Authorised Representative Ms Debashri Saha | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by Medisys Biotech Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by M/S K Patel International | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by K Patel International | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Pending |
To see the full case history of Novatro Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novatro Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novatro Laboratories Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
Active EPFO establishments
1
GST
Novatro Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICN2823K1ZF | Uttarakhand | Active | 05 Jul 2022 |
To see the full GST registrations and return filing status of Novatro Laboratories Private Limited, buy the company report.
Recent activity
Novatro Laboratories Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Mohan Kumar Jha ceased to be Additional Director on 11 Jul 2023.
AGM
Novatro Laboratories Private Limited last Annual general meeting of members was held on 31 Dec 2023 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 50.00 Lakh with Charge ID 100861996 was registered on 29 Dec 2023.
Ceased
Mohan Kumar Jha ceased to be Additional Director.
Filing
Novatro Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Appointed
Mohan Kumar Jha was appointed as Additional Director.
Appointed
Sharat Chandra Jha was appointed as Director.
Appointed
Tilak Ram was appointed as Director.
Incorporation
31 May 2022
Novatro Laboratories Private Limited was registered on 31 May 2022 with Roc Delhi I & aged 4 years 5 months as per MCA records.
Frequently asked questions
Novatro Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2022 (4+ years old) and is registered under CIN U24230DL2022PTC399347.
Novatro Laboratories has 2 current directors:
- Sharat Chandra Jha - Director
- Tilak Ram - Director
The latest financial statements of Novatro Laboratories on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 December 2023. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Novatro Laboratories is 05AAICN2823K1ZF, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Novatro Laboratories is U24230DL2022PTC399347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novatro Laboratories has 13 court cases on record: 13 filed against it. 13 are pending.
Novatro Laboratories was incorporated on 31 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Novatro Laboratories by revenue are Zevemed Healthcare Private Limited, Organon Homoeo Laboratory Pvt Ltd, Emmchak Formulations Private Limited, Unicorn Pharmachem Private Limited, Asterisk Laboratories India Private Limited and 5 more, all in the Pharma industry (Formulations).
Mohan Kumar Jha ceased to be Additional Director on 11 Jul 2023. Mohan Kumar Jha was appointed as Additional Director on 02 Aug 2022. Sharat Chandra Jha was appointed as Director on 31 May 2022. Novatro Laboratories has 4 board changes on record in total.
Yes, Novatro Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0031477).
The registered office of Novatro Laboratories is at Office No – 606 6th Floor Laxmi Deep Building District Centre, New Delhi, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages